The New York State Department of Health issued an advisory Aug. 14 asking providers to discontinue use of ciprofloxacin as a post-exposure prophylaxis for close contacts of patients with meningococcal disease.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
